Interim analysis of patient-reported outcome compliance and dosimetry in a phase 3 randomized clinical trial of oesophagus-sparing spinal radiotherapy.
Anna Mann NielsenKatrine Smedegaard StormMichael R T LaursenVanja Remberg GramLaura Ann RechnerWiviann OttossonMorten Hiul SuppliPatrik SiboltClaus Preibisch BehrensIvan Richter VogeliusGitte Fredberg PerssonPublished in: Acta oncologica (Stockholm, Sweden) (2023)
Compliance was lower than anticipated and interventions to maintain study power are needed.